About
Lung Treatments
Areas of Focus
Categories
Biologics & BiopharmaceuticalSouthwestern U.S.
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
47
By Phase
PHASE2: 1PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05938036Lead Sponsor
Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS
PHASE2Active, not recruiting
15 participants
Started: Dec 1, 2023 · Completed: Jul 1, 2027
NCT05426746Lead Sponsor
First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALT-100
PHASE1Completed
32 participants
Started: Jul 5, 2022 · Completed: May 18, 2023
Funding History (1)
D
Jun 27, 2022
Locations (1)
Headquarters
Tucson, AZ, United States
Map
Loading map...